PCI-27483
Product Specifications
UNSPSC Description
PCI-27483 is a FVIIa/tissue factor inhibitor, with antitumour effects.
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/PCI-27483.html
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(O)C[C@@H](C(O)=O)NC(CC1=CC(C2=CC(S(=O)(N)=O)=CC=C2O)=C(O)C(C3=NC4=CC=C(C(N)=N)C=C4N3)=C1)=O
Molecular Weight
596.57
References & Citations
[1]Gómez-Outes A, et al. New parenteral anticoagulants in development. Ther Adv Cardiovasc Dis. 2011 Feb;5(1):33-59.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-16382/PCI-27483-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-16382/PCI-27483-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
871266-63-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal CCL15/MIP-1 delta Antibody (001) [Allophycocyanin]](https://cdn.genprice.uk/genprice/genprice5.png)
NBP2-89703APC 0.1 mL
Rabbit Monoclonal CCL15/MIP-1 delta Antibody (001) [Allophycocyanin]
Ask
View Details 
MBS6298587-01 0.1 mL
FCAR, ID (FCAR, CD89, Immunoglobulin alpha Fc receptor, CD89) (MaxLight 405)
Ask
View Details MBS6298587-02 5x 0.1 mL
FCAR, ID (FCAR, CD89, Immunoglobulin alpha Fc receptor, CD89) (MaxLight 405)
Ask
View Details